Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VENUS REMEDIES BIOCON VENUS REMEDIES/
BIOCON
 
P/E (TTM) x 15.0 19.7 76.4% View Chart
P/BV x 0.9 1.8 52.6% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 VENUS REMEDIES   BIOCON
EQUITY SHARE DATA
    VENUS REMEDIES
Mar-23
BIOCON
Mar-23
VENUS REMEDIES/
BIOCON
5-Yr Chart
Click to enlarge
High Rs379388 97.7%   
Low Rs145192 75.7%   
Sales per share (Unadj.) Rs415.593.1 446.4%  
Earnings per share (Unadj.) Rs19.95.4 371.0%  
Cash flow per share (Unadj.) Rs44.014.6 301.0%  
Dividends per share (Unadj.) Rs01.50 0.0%  
Avg Dividend yield %00.5 0.0%  
Book value per share (Unadj.) Rs344.3146.5 235.0%  
Shares outstanding (eoy) m13.371,200.60 1.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.63.1 20.3%   
Avg P/E ratio x13.254.1 24.4%  
P/CF ratio (eoy) x5.919.8 30.0%  
Price / Book Value ratio x0.82.0 38.5%  
Dividend payout %028.0 0.0%   
Avg Mkt Cap Rs m3,501347,814 1.0%   
No. of employees `000NANA-   
Total wages/salary Rs m57021,810 2.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5,555111,742 5.0%  
Other income Rs m1037,681 1.3%   
Total revenues Rs m5,658119,423 4.7%   
Gross profit Rs m60216,611 3.6%  
Depreciation Rs m32311,131 2.9%   
Interest Rs m34,190 0.1%   
Profit before tax Rs m3798,971 4.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1142,541 4.5%   
Profit after tax Rs m2666,430 4.1%  
Gross profit margin %10.814.9 72.9%  
Effective tax rate %30.028.3 105.8%   
Net profit margin %4.85.8 83.1%  
BALANCE SHEET DATA
Current assets Rs m3,230123,340 2.6%   
Current liabilities Rs m82685,107 1.0%   
Net working cap to sales %43.334.2 126.5%  
Current ratio x3.91.4 269.9%  
Inventory Days Days37129 28.6%  
Debtors Days Days504117 431.6%  
Net fixed assets Rs m2,781394,078 0.7%   
Share capital Rs m1346,003 2.2%   
"Free" reserves Rs m4,470169,926 2.6%   
Net worth Rs m4,603175,929 2.6%   
Long term debt Rs m387152,905 0.3%   
Total assets Rs m6,011517,418 1.2%  
Interest coverage x130.03.1 4,139.3%   
Debt to equity ratio x0.10.9 9.7%  
Sales to assets ratio x0.90.2 427.9%   
Return on assets %4.52.1 217.7%  
Return on equity %5.83.7 157.9%  
Return on capital %7.74.0 191.4%  
Exports to sales %03.1 0.0%   
Imports to sales %06.0 0.0%   
Exports (fob) Rs mNA3,467 0.0%   
Imports (cif) Rs mNA6,654 0.0%   
Fx inflow Rs m03,467 0.0%   
Fx outflow Rs m06,654 0.0%   
Net fx Rs m0-3,187 -0.0%   
CASH FLOW
From Operations Rs m36618,525 2.0%  
From Investments Rs m-508-142,818 0.4%  
From Financial Activity Rs m-6130,487 -0.0%  
Net Cashflow Rs m-2206,411 -3.4%  

Share Holding

Indian Promoters % 41.8 40.4 103.5%  
Foreign collaborators % 0.0 20.3 -  
Indian inst/Mut Fund % 1.6 21.1 7.5%  
FIIs % 1.6 6.6 24.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.2 39.4 148.0%  
Shareholders   19,560 434,339 4.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VENUS REMEDIES With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on VENUS REMEDIES vs Biocon

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

VENUS REMEDIES vs Biocon Share Price Performance

Period VENUS REMEDIES Biocon S&P BSE HEALTHCARE
1-Day 7.05% 2.92% 1.18%
1-Month -4.10% -2.53% -0.75%
1-Year 103.11% 30.52% 61.82%
3-Year CAGR 4.62% -13.55% 18.16%
5-Year CAGR 58.05% -2.73% 19.79%

* Compound Annual Growth Rate

Here are more details on the VENUS REMEDIES share price and the Biocon share price.

Moving on to shareholding structures...

The promoters of VENUS REMEDIES hold a 41.8% stake in the company. In case of Biocon the stake stands at 60.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of VENUS REMEDIES and the shareholding pattern of Biocon.

Finally, a word on dividends...

In the most recent financial year, VENUS REMEDIES paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Biocon paid Rs 1.5, and its dividend payout ratio stood at 28.0%.

You may visit here to review the dividend history of VENUS REMEDIES, and the dividend history of Biocon.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.